Vivimed Labs Ltd has acquired a manufacturing facility of Chennai-based Actavis Pharma Manufacturing Ltd for Rs 122 crore.
The Hyderabad-based Vivimed has entered into an agreement to this effect with Actavis Pharma Manufacturing’s solid oral dosage facility in Alathur, Tamil Nadu, the BSE was informed on Thursday.
The facility is being acquired from Actavis Holding Asia BV, an affiliate of Actavis Inc. The acquisition was being funded from internal accruals and debt.
The manufacturing facility has been approved by the US Food and Drug Administration in April 2007 and has a capacity to produce 1.2 billion solid oral dosages per annum.
Vivimed Labs’ scrip gained five per cent on the BSE on Thursday to close at Rs 106.10.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.